Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View WOK insider activity ↗

WOKWORK Medical Technology Group LTD

THE LATEST REPORTED YEAR

The company reported a loss.

$1.07M net loss for the year ended September 30, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$9.85MYear ended September 30, 2025
Profit or loss-$1.07MYear ended September 30, 2025
Cash from the business$6.24MYear ended September 30, 2025
Total assets$33.16MAs of September 30, 2025
Total liabilities$11.99MAs of September 30, 2025
Cash & equivalents$4.09MAs of September 30, 2025
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$19.71M
2022-09
$13.57M
2023-09
$11.51M
2024-09
$9.85M
2025-09

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
October 1, 2024 – September 30, 2025$9,848,715January 30, 202620-F ↗
October 1, 2023 – September 30, 2024$11,506,440January 30, 202620-F ↗
October 1, 2022 – September 30, 2023$13,565,951January 30, 202620-F ↗
October 1, 2021 – September 30, 2022$19,711,290February 14, 202520-F ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · Retrieved October 15, 2026

Response SHA-256: 7552b4dac3377e35f16fbb1e911dce3a6f5a20e285a1dccbfa0b05f9646c24e5

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.